Figure 1.

The process of data collection. We selected the studies using high-quality scRNA-seq platforms for human disease. The original authors of these literatures have developed their specific pipeline for analysing their raw data so we manually extracted the results of their cell-type-specific genes into SC2disease. In addition, to to improve the comparability between different studies, we designed a unified pipeline to reanalyze the gene expression matrix of each study. We also put these reanalyzed results into SC2disease. Finally, these cell-type-specific genes and their related information constructed SC2disease.